| HCL | hairy-cell leukemia; human cultured lymphoblasts |
|---|---|
| HCl | hydrogen chloride |
| Apo | Apomorphine HCl |
|---|---|
| HCL | Hairy Cell Leukaemia |
| DPPE | N,N-Diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine.HCl |
| Gu.HCl | guanidinium chloride |
| Gdn-HCl | guanidinium hydrochloride |
| betaxolol | <chemical> 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol. A cardioselective beta-1-adrenergic antagonist with no partial agonist activity. The drug is a potent antihypertensive agent and has been effective in the treatment of patients with glaucoma and airway diseases. Pharmacological action: adrenergic beta-antagonists, antihypertensive agents, sympatholytics. Chemical name: 2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)- (12 Dec 1998) |
|---|---|
| betaxolol hydrochloride | 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-isopropylaminopropan-2-ol hydrochloride;a beta-adrenergic blocking agent used primarily in the treatment of ocular hypertension and chronic open-angle glaucoma. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
º£Å鯽Á¡¾È¾× - »õâ
|
Alcon |
E07370171 | Betaxolol HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
º£Å¸Á¹Á¤ - »õâ
|
³Ø½ºÆÊÄÚ¸®¾Æ |
A66350801 | Betaxolol HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
º£Å鯽¿¡½ºÁ¡¾È¾× - »õâ
|
Alcon |
W07370101 | Betaxolol HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
ºÎ±¤ÄÌ·ÐÁ¤ - »õâ
|
ºÎ±¤¾àǰ |
A13101751 | Betaxolol HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
º£Å¹Á¤ - »õâ
|
Áø¾çÁ¦¾à |
A10702461 | Betaxolol HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
º£Å¹Á¤10mg - »õâ
|
Áø¾çÁ¦¾à |
A10750481 | Betaxolol HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
ºÎ±¤ÄÌ·ÐÁ¤10mg - »õâ
|
ºÎ±¤¾àǰ |
A13102141 | Betaxolol HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
º£Å¸¼ÖÁ¤10mg - »õâ
|
Çѱ¹ÇÁ¶óÀÓÁ¦¾à |
A62753021 | Betaxolol HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
º£Å¸¼ÖÁ¤20mg - »õâ
|
Çѱ¹ÇÁ¶óÀÓÁ¦¾à |
A62753031 | Betaxolol HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
·ç¾Æ·ÑÁ¡¾È¾× - »õâ
|
»ïõ´çÁ¦¾à |
A08451791 | Betaxolol HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|